Jiangsu Hengrui Medicine Co Ltd (600276) — Cash Flow Reinvestment Rate
Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥446.90 Million (capex CN¥446.90 Million ) from operating cash flow of CN¥4.81 Billion. See how much free cash does Jiangsu Hengrui Medicine Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Hengrui Medicine Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see Jiangsu Hengrui Medicine Co Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for Jiangsu Hengrui Medicine Co Ltd. See 600276 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥2.00 Billion | CN¥7.42 Billion | CN¥1.97 Billion | ▼ -50.5% |
| 2023 | 0.55x | CN¥4.17 Billion | CN¥7.64 Billion | CN¥1.48 Billion | ▼ -71.0% |
| 2022 | 1.88x | CN¥2.38 Billion | CN¥1.27 Billion | CN¥1.99 Billion | ▲ +216.9% |
| 2021 | 0.59x | CN¥2.51 Billion | CN¥4.22 Billion | CN¥1.66 Billion | ▼ -20.4% |
| 2020 | 0.75x | CN¥2.56 Billion | CN¥3.43 Billion | CN¥554.33 Million | ▲ +26.4% |
| 2019 | 0.59x | CN¥2.25 Billion | CN¥3.82 Billion | CN¥561.35 Million | ▼ -47.3% |
| 2018 | 1.12x | CN¥3.11 Billion | CN¥2.77 Billion | CN¥529.11 Million | ▼ -16.7% |
| 2017 | 1.35x | CN¥3.43 Billion | CN¥2.55 Billion | CN¥380.30 Million | ▲ +31.4% |
| 2016 | 1.02x | CN¥2.65 Billion | CN¥2.59 Billion | CN¥1.11 Billion | ▲ +395.4% |
| 2015 | 0.21x | CN¥470.55 Million | CN¥2.28 Billion | CN¥394.09 Million | ▲ +9.0% |
| 2014 | 0.19x | CN¥298.52 Million | CN¥1.57 Billion | CN¥298.52 Million | ▼ -42.9% |
| 2013 | 0.33x | CN¥453.30 Million | CN¥1.36 Billion | CN¥453.30 Million | ▼ -31.8% |
| 2012 | 0.49x | CN¥466.83 Million | CN¥958.37 Million | CN¥466.83 Million | ▼ -52.5% |
| 2011 | 1.02x | CN¥540.27 Million | CN¥527.36 Million | CN¥540.27 Million | ▲ +37.9% |
| 2010 | 0.74x | CN¥286.73 Million | CN¥385.95 Million | CN¥286.73 Million | ▲ +130.3% |
| 2009 | 0.32x | CN¥141.65 Million | CN¥439.12 Million | CN¥141.65 Million | ▼ -65.9% |
| 2008 | 0.95x | CN¥111.21 Million | CN¥117.46 Million | CN¥111.21 Million | ▲ +210.0% |
| 2007 | 0.31x | CN¥66.85 Million | CN¥218.87 Million | CN¥66.85 Million | ▼ -5.8% |
| 2006 | 0.32x | CN¥86.29 Million | CN¥266.18 Million | CN¥86.29 Million | ▲ +17.1% |
| 2005 | 0.28x | CN¥63.07 Million | CN¥227.88 Million | CN¥63.07 Million | ▼ -26.7% |
| 2004 | 0.38x | CN¥79.11 Million | CN¥209.41 Million | CN¥79.11 Million | ▼ -76.1% |
| 2003 | 1.58x | CN¥216.62 Million | CN¥136.82 Million | CN¥216.62 Million | ▼ -35.8% |
| 2002 | 2.47x | CN¥122.90 Million | CN¥49.84 Million | CN¥122.90 Million | ▼ -89.7% |
| 2001 | 23.99x | CN¥275.58 Million | CN¥11.49 Million | CN¥275.58 Million | ▲ +478.2% |
| 2000 | 4.15x | CN¥81.34 Million | CN¥19.61 Million | CN¥81.34 Million | ▲ +591.8% |
| 1999 | 0.60x | CN¥20.32 Million | CN¥33.89 Million | CN¥20.32 Million | — |